|
1
|
Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
|
N Engl J Med
|
2010
|
9.19
|
|
2
|
Estimated radiation dose associated with cardiac CT angiography.
|
JAMA
|
2009
|
8.31
|
|
3
|
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
|
Lancet
|
2007
|
6.77
|
|
4
|
Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
|
JAMA
|
2006
|
4.18
|
|
5
|
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.
|
N Engl J Med
|
2007
|
3.84
|
|
6
|
Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
|
JAMA
|
2006
|
3.78
|
|
7
|
Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
|
N Engl J Med
|
2005
|
3.75
|
|
8
|
Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement.
|
Circulation
|
2010
|
3.68
|
|
9
|
Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial.
|
JAMA
|
2003
|
3.52
|
|
10
|
Radiation dose estimates from cardiac multislice computed tomography in daily practice: impact of different scanning protocols on effective dose estimates.
|
Circulation
|
2006
|
3.26
|
|
11
|
Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
|
J Am Coll Cardiol
|
2009
|
3.15
|
|
12
|
Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel.
|
Circulation
|
2004
|
3.12
|
|
13
|
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
|
J Am Coll Cardiol
|
2008
|
3.11
|
|
14
|
A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel.
|
N Engl J Med
|
2004
|
3.07
|
|
15
|
Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study.
|
Lancet
|
2006
|
2.75
|
|
16
|
Prognostic value of coronary computed tomographic angiography for prediction of cardiac events in patients with suspected coronary artery disease.
|
JACC Cardiovasc Imaging
|
2009
|
2.70
|
|
17
|
Association of ST-elevation and non-ST-elevation presentation on ECG with transmurality and size of myocardial infarction as assessed by contrast-enhanced magnetic resonance imaging.
|
J Electrocardiol
|
2013
|
2.64
|
|
18
|
Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies.
|
Circulation
|
2005
|
2.61
|
|
19
|
Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial.
|
J Am Coll Cardiol
|
2003
|
2.53
|
|
20
|
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
|
JAMA
|
2005
|
2.53
|
|
21
|
Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period.
|
Eur Heart J
|
2009
|
2.47
|
|
22
|
Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment.
|
Thromb Haemost
|
2008
|
2.46
|
|
23
|
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.
|
J Am Coll Cardiol
|
2008
|
2.38
|
|
24
|
Validation of the Bleeding Academic Research Consortium definition of bleeding in patients with coronary artery disease undergoing percutaneous coronary intervention.
|
Circulation
|
2012
|
2.32
|
|
25
|
Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents.
|
Circulation
|
2006
|
2.18
|
|
26
|
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
|
JAMA
|
2004
|
2.17
|
|
27
|
Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial.
|
Lancet
|
2011
|
2.10
|
|
28
|
The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG).
|
Eur Heart J
|
2008
|
2.10
|
|
29
|
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
|
Thromb Haemost
|
2009
|
2.09
|
|
30
|
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.
|
BMJ
|
2008
|
2.09
|
|
31
|
Prevalence of noncalcified coronary plaques by 64-slice computed tomography in patients with an intermediate risk for significant coronary artery disease.
|
J Am Coll Cardiol
|
2006
|
2.08
|
|
32
|
Image quality and radiation exposure with a low tube voltage protocol for coronary CT angiography results of the PROTECTION II Trial.
|
JACC Cardiovasc Imaging
|
2010
|
2.06
|
|
33
|
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.
|
Eur Heart J
|
2009
|
2.06
|
|
34
|
Image quality and radiation exposure with prospectively ECG-triggered axial scanning for coronary CT angiography: the multicenter, multivendor, randomized PROTECTION-III study.
|
JACC Cardiovasc Imaging
|
2012
|
2.05
|
|
35
|
Characterization of paroxysmal and persistent atrial fibrillation in the human left atrium during initiation and sustained episodes.
|
J Cardiovasc Electrophysiol
|
2002
|
2.04
|
|
36
|
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.
|
Eur Heart J
|
2008
|
2.01
|
|
37
|
Impact of a reduced tube voltage on CT angiography and radiation dose: results of the PROTECTION I study.
|
JACC Cardiovasc Imaging
|
2009
|
1.99
|
|
38
|
Risk stratification after acute myocardial infarction by heart rate turbulence.
|
Circulation
|
2003
|
1.96
|
|
39
|
Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
|
J Am Coll Cardiol
|
2010
|
1.93
|
|
40
|
Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention.
|
Eur Heart J
|
2009
|
1.92
|
|
41
|
Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR.
|
Clin Chem
|
2002
|
1.90
|
|
42
|
Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction.
|
Eur Heart J
|
2006
|
1.86
|
|
43
|
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials.
|
Eur Heart J
|
2012
|
1.85
|
|
44
|
Pharmacokinetics of clopidogrel after administration of a high loading dose.
|
Thromb Haemost
|
2004
|
1.84
|
|
45
|
Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial.
|
Eur Heart J
|
2009
|
1.81
|
|
46
|
Non-invasive coronary computed tomographic angiography for patients with suspected coronary artery disease: the Coronary Angiography by Computed Tomography with the Use of a Submillimeter resolution (CACTUS) trial.
|
Eur Heart J
|
2007
|
1.77
|
|
47
|
Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction.
|
Eur Heart J
|
2007
|
1.76
|
|
48
|
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
|
J Am Coll Cardiol
|
2009
|
1.73
|
|
49
|
Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement.
|
Am Heart J
|
2004
|
1.73
|
|
50
|
A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days.
|
Eur Heart J
|
2007
|
1.71
|
|
51
|
Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin.
|
Am Heart J
|
2011
|
1.70
|
|
52
|
Evolution of left ventricular ejection fraction and its relationship to infarct size after acute myocardial infarction.
|
J Am Coll Cardiol
|
2007
|
1.69
|
|
53
|
Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial.
|
Circulation
|
2009
|
1.69
|
|
54
|
Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial.
|
Eur Heart J
|
2005
|
1.68
|
|
55
|
Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer.
|
JACC Cardiovasc Interv
|
2009
|
1.67
|
|
56
|
Prognostic value of uric acid in patients with acute coronary syndromes.
|
Am J Cardiol
|
2012
|
1.67
|
|
57
|
No association of chromosome 9p21.3 variation with clinical and angiographic outcomes after placement of drug-eluting stents.
|
JACC Cardiovasc Interv
|
2009
|
1.67
|
|
58
|
Myocardial perfusion grade, myocardial salvage indices and long-term mortality in patients with acute myocardial infarction and full restoration of epicardial blood flow after primary percutaneous coronary intervention.
|
Rev Esp Cardiol
|
2010
|
1.65
|
|
59
|
Gender and restenosis after coronary artery stenting.
|
Eur Heart J
|
2003
|
1.62
|
|
60
|
TaqMan systems for genotyping of disease-related polymorphisms present in the gene encoding apolipoprotein E.
|
Clin Chem Lab Med
|
2002
|
1.61
|
|
61
|
CD14 gene -159C/T polymorphism is not associated with coronary artery disease and myocardial infarction.
|
Am Heart J
|
2002
|
1.59
|
|
62
|
Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.
|
JAMA
|
2005
|
1.57
|
|
63
|
Impact of P-glycoprotein on clopidogrel absorption.
|
Clin Pharmacol Ther
|
2006
|
1.57
|
|
64
|
Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population.
|
Eur Heart J
|
2006
|
1.56
|
|
65
|
Relation of fibrinogen level with cardiovascular events in patients with coronary artery disease.
|
Am J Cardiol
|
2013
|
1.56
|
|
66
|
ISAR-REACT 3A: a study of reduced dose of unfractionated heparin in biomarker negative patients undergoing percutaneous coronary intervention.
|
Eur Heart J
|
2010
|
1.56
|
|
67
|
Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions.
|
Circulation
|
2006
|
1.55
|
|
68
|
Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial.
|
Eur Heart J
|
2010
|
1.55
|
|
69
|
Feasibility of dual-source cardiac CT angiography with high-pitch scan protocols.
|
J Cardiovasc Comput Tomogr
|
2009
|
1.54
|
|
70
|
Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes.
|
Eur Heart J
|
2008
|
1.54
|
|
71
|
Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or paclitaxel-eluting stents.
|
J Am Coll Cardiol
|
2006
|
1.54
|
|
72
|
Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment.
|
Drug Saf
|
2009
|
1.54
|
|
73
|
No replication of association between estrogen receptor alpha gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent.
|
Circulation
|
2005
|
1.54
|
|
74
|
Proteolysis of tissue factor pathway inhibitor-1 by thrombolysis in acute myocardial infarction.
|
Circulation
|
2002
|
1.52
|
|
75
|
Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.
|
J Am Coll Cardiol
|
2012
|
1.49
|
|
76
|
The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT.
|
JACC Cardiovasc Imaging
|
2013
|
1.49
|
|
77
|
Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting.
|
Am Heart J
|
2005
|
1.48
|
|
78
|
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial.
|
Eur Heart J
|
2007
|
1.47
|
|
79
|
One-year outcomes with abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary interventions in patients with non-ST-segment elevation myocardial infarction: updated results from the ISAR-REACT 4 trial.
|
EuroIntervention
|
2013
|
1.47
|
|
80
|
Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi.
|
Eur Heart J Cardiovasc Imaging
|
2013
|
1.47
|
|
81
|
Association of a genetic variant of endothelial nitric oxide synthase with the 1 year clinical outcome after coronary stent placement.
|
Eur Heart J
|
2003
|
1.46
|
|
82
|
Protective effect of the CYP2C19 *17 polymorphism with increased activation of clopidogrel on cardiovascular events.
|
Am Heart J
|
2010
|
1.46
|
|
83
|
Haplotypes and 5A/6A polymorphism of the matrix metalloproteinase-3 gene in coronary disease: case-control study and a meta-analysis.
|
Atherosclerosis
|
2009
|
1.45
|
|
84
|
Drug-eluting stents versus bare-metal stents in diabetic patients with ST-segment elevation acute myocardial infarction: a pooled analysis of individual patient data from seven randomized trials.
|
Rev Esp Cardiol
|
2009
|
1.45
|
|
85
|
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.
|
J Am Coll Cardiol
|
2004
|
1.45
|
|
86
|
Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
|
Catheter Cardiovasc Interv
|
2011
|
1.44
|
|
87
|
Thoracic radiotherapy in patients with lymphoma and restenosis after coronary stent placement.
|
Catheter Cardiovasc Interv
|
2007
|
1.43
|
|
88
|
Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample.
|
Int J Cardiol
|
2007
|
1.43
|
|
89
|
Five-year outcome of patients with acute myocardial infarction enrolled in a randomised trial assessing the value of abciximab during coronary artery stenting.
|
Eur Heart J
|
2004
|
1.43
|
|
90
|
Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
|
Cardiovasc Revasc Med
|
2013
|
1.42
|
|
91
|
Angiotensin I-converting enzyme (ACE) inhibitors and restenosis after coronary artery stenting in patients with the DD genotype of the ACE gene.
|
J Am Coll Cardiol
|
2003
|
1.41
|
|
92
|
Improved noninvasive assessment of coronary artery bypass grafts with 64-slice computed tomographic angiography in an unselected patient population.
|
J Am Coll Cardiol
|
2007
|
1.40
|
|
93
|
Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction.
|
Circulation
|
2006
|
1.40
|
|
94
|
5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction.
|
J Am Coll Cardiol
|
2010
|
1.39
|
|
95
|
Bivalirudin reduces platelet and monocyte activation after elective percutaneous coronary intervention.
|
Thromb Haemost
|
2009
|
1.39
|
|
96
|
Patterns of presentation and outcomes of patients with acute coronary syndromes.
|
Cardiology
|
2009
|
1.39
|
|
97
|
[Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].
|
Rev Esp Cardiol
|
2008
|
1.38
|
|
98
|
2-year clinical and angiographic outcomes from a randomized trial of polymer-free dual drug-eluting stents versus polymer-based Cypher and Endeavor [corrected] drug-eluting stents.
|
J Am Coll Cardiol
|
2010
|
1.38
|
|
99
|
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk).
|
Eur Heart J
|
2008
|
1.37
|
|
100
|
Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
|
N Engl J Med
|
2008
|
1.37
|
|
101
|
Absorption, metabolization, and antiplatelet effects of 300-, 600-, and 900-mg loading doses of clopidogrel: results of the ISAR-CHOICE (Intracoronary Stenting and Antithrombotic Regimen: Choose Between 3 High Oral Doses for Immediate Clopidogrel Effect) Trial.
|
Circulation
|
2005
|
1.34
|
|
102
|
Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction.
|
JACC Cardiovasc Imaging
|
2009
|
1.32
|
|
103
|
Stem cell mobilization by granulocyte colony-stimulating factor for myocardial recovery after acute myocardial infarction: a meta-analysis.
|
J Am Coll Cardiol
|
2008
|
1.31
|
|
104
|
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting.
|
Eur Heart J
|
2011
|
1.29
|
|
105
|
Biatrial multisite mapping of atrial premature complexes triggering onset of atrial fibrillation.
|
Am J Cardiol
|
2002
|
1.28
|
|
106
|
Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes.
|
Circ Res
|
2007
|
1.27
|
|
107
|
Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion.
|
Circulation
|
2004
|
1.24
|
|
108
|
Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.
|
J Am Coll Cardiol
|
2006
|
1.24
|
|
109
|
Predictive factors and impact of no reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction.
|
Circ Cardiovasc Interv
|
2010
|
1.24
|
|
110
|
Essential myosin light chain as a target for caspase-3 in failing myocardium.
|
Proc Natl Acad Sci U S A
|
2002
|
1.21
|
|
111
|
Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.
|
N Engl J Med
|
2011
|
1.20
|
|
112
|
Sirolimus and Paclitaxel on polymer-based drug-eluting stents: similar but different.
|
J Am Coll Cardiol
|
2006
|
1.20
|
|
113
|
Randomized trial of paclitaxel- and sirolimus-eluting stents in small coronary vessels.
|
Eur Heart J
|
2006
|
1.18
|
|
114
|
Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction.
|
FASEB J
|
2005
|
1.18
|
|
115
|
Acute myocardial infarction: serial cardiac MR imaging shows a decrease in delayed enhancement of the myocardium during the 1st week after reperfusion.
|
Radiology
|
2010
|
1.17
|
|
116
|
Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
|
Clin Endocrinol (Oxf)
|
2007
|
1.16
|
|
117
|
Images in cardiovascular medicine. Assessment of double chamber right ventricle by magnetic resonance imaging.
|
Circulation
|
2002
|
1.14
|
|
118
|
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial.
|
Lancet
|
2002
|
1.14
|
|
119
|
Randomized trial of a nonpolymer-based rapamycin-eluting stent versus a polymer-based paclitaxel-eluting stent for the reduction of late lumen loss.
|
Circulation
|
2006
|
1.13
|
|
120
|
Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease.
|
Eur Heart J
|
2013
|
1.11
|
|
121
|
Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.
|
Am J Cardiol
|
2005
|
1.11
|
|
122
|
Prognostic value of coronary computed tomographic angiography in diabetic patients without known coronary artery disease.
|
Diabetes Care
|
2010
|
1.11
|
|
123
|
Prognostic value of myocardial salvage achieved by reperfusion therapy in patients with acute myocardial infarction.
|
J Nucl Med
|
2004
|
1.09
|
|
124
|
Gender and myocardial salvage after reperfusion treatment in acute myocardial infarction.
|
J Am Coll Cardiol
|
2005
|
1.09
|
|
125
|
Prognostic value of coronary computed tomographic angiography in comparison with calcium scoring and clinical risk scores.
|
Circ Cardiovasc Imaging
|
2010
|
1.09
|
|
126
|
A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.
|
Eur Heart J
|
2009
|
1.08
|
|
127
|
Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
|
J Am Coll Cardiol
|
2006
|
1.07
|
|
128
|
Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy.
|
Circulation
|
2004
|
1.07
|
|
129
|
Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial.
|
J Am Coll Cardiol
|
2011
|
1.07
|
|
130
|
Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients.
|
Catheter Cardiovasc Interv
|
2011
|
1.07
|
|
131
|
Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
|
Circulation
|
2004
|
1.06
|
|
132
|
Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.
|
Arterioscler Thromb Vasc Biol
|
2006
|
1.04
|
|
133
|
Membrane-type serine protease-1/matriptase induces interleukin-6 and -8 in endothelial cells by activation of protease-activated receptor-2: potential implications in atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2007
|
1.04
|
|
134
|
Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction.
|
Eur Heart J
|
2004
|
1.04
|
|
135
|
Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
|
Circulation
|
2005
|
1.03
|
|
136
|
Comparison of sequential and helical scanning for radiation dose and image quality: results of the Prospective Multicenter Study on Radiation Dose Estimates of Cardiac CT Angiography (PROTECTION) I Study.
|
AJR Am J Roentgenol
|
2010
|
1.02
|
|
137
|
Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention.
|
JAMA
|
2002
|
1.01
|
|
138
|
C825T polymorphism of the G-protein beta3 subunit gene and atrial fibrillation: association of the TT genotype with a reduced risk for atrial fibrillation.
|
Am Heart J
|
2004
|
1.01
|
|
139
|
Prognostic value of N-terminal pro-brain natriuretic peptide in patients with chronic stable angina.
|
Circulation
|
2005
|
1.00
|
|
140
|
Impact of perfusion restoration at epicardial and tissue levels on markers of myocardial necrosis and clinical outcome of patients with acute myocardial infarction.
|
EuroIntervention
|
2011
|
1.00
|
|
141
|
Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
|
Thromb Haemost
|
2005
|
1.00
|
|
142
|
Long-term outcome after coronary stenting.
|
Curr Control Trials Cardiovasc Med
|
2000
|
1.00
|
|
143
|
P2Y12 gene H2 haplotype is not associated with increased adenosine diphosphate-induced platelet aggregation after initiation of clopidogrel therapy with a high loading dose.
|
Blood Coagul Fibrinolysis
|
2005
|
1.00
|
|
144
|
Ticagrelor--is there need for a new player in the antiplatelet-therapy field?
|
N Engl J Med
|
2009
|
0.99
|
|
145
|
Quantitative measurement of infarct size by contrast-enhanced magnetic resonance imaging early after acute myocardial infarction: comparison with single-photon emission tomography using Tc99m-sestamibi.
|
J Am Coll Cardiol
|
2005
|
0.98
|
|
146
|
Cardiovascular risk assessment based on the quantification of coronary calcium in contrast-enhanced coronary computed tomography angiography.
|
Eur Heart J Cardiovasc Imaging
|
2011
|
0.96
|
|
147
|
Predictive value of basal C-reactive protein levels for myocardial salvage in patients with acute myocardial infarction is dependent on the type of reperfusion treatment.
|
Eur Heart J
|
2003
|
0.95
|
|
148
|
Polymer-free sirolimus- and probucol-eluting versus new generation zotarolimus-eluting stents in coronary artery disease: the Intracoronary Stenting and Angiographic Results: Test Efficacy of Sirolimus- and Probucol-Eluting versus Zotarolimus-eluting Stents (ISAR-TEST 5) trial.
|
Circulation
|
2011
|
0.95
|
|
149
|
Retracted
Novel role of the CXC chemokine receptor 3 in inflammatory response to arterial injury: involvement of mTORC1.
|
Circ Res
|
2008
|
0.95
|
|
150
|
Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window.
|
J Am Coll Cardiol
|
2010
|
0.95
|
|
151
|
Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
|
J Am Coll Cardiol
|
2006
|
0.94
|
|
152
|
Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
|
Am Heart J
|
2007
|
0.94
|
|
153
|
Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting.
|
Eur Heart J
|
2007
|
0.94
|
|
154
|
Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction.
|
Am J Cardiol
|
2005
|
0.94
|
|
155
|
Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease.
|
Am Heart J
|
2007
|
0.93
|
|
156
|
Thrombolysis in myocardial infarction myocardial perfusion grade in angiography correlates with myocardial salvage in patients with acute myocardial infarction treated with stenting or thrombolysis.
|
J Am Coll Cardiol
|
2003
|
0.93
|
|
157
|
Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy.
|
Eur Heart J
|
2011
|
0.92
|
|
158
|
Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
|
Cardiovasc Res
|
2005
|
0.92
|
|
159
|
The chromosome 9p21 region and myocardial infarction in a European population.
|
Atherosclerosis
|
2011
|
0.92
|
|
160
|
The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts.
|
Biomaterials
|
2008
|
0.92
|
|
161
|
Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting.
|
Am J Med
|
2003
|
0.92
|
|
162
|
Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.
|
Eur Heart J
|
2005
|
0.91
|
|
163
|
Five-year clinical outcomes of a polymer-free sirolimus-eluting stent versus a permanent polymer paclitaxel-eluting stent: final results of the intracoronary stenting and angiographic restenosis - test equivalence between two drug-eluting stents (ISAR-TEST) trial.
|
Catheter Cardiovasc Interv
|
2012
|
0.91
|
|
164
|
MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent.
|
Circ Cardiovasc Imaging
|
2011
|
0.91
|
|
165
|
Impact of smoking on antiplatelet effect of clopidogrel and prasugrel after loading dose and on maintenance therapy.
|
Am Heart J
|
2011
|
0.91
|
|
166
|
Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
|
Thromb Haemost
|
2009
|
0.91
|
|
167
|
Stem cell mobilization by granulocyte-colony-stimulating factor in acute myocardial infarction: lessons from the REVIVAL-2 trial.
|
Nat Clin Pract Cardiovasc Med
|
2007
|
0.91
|
|
168
|
Tumor necrosis factor-alpha, lymphotoxin-alpha, and interleukin-10 gene polymorphisms and restenosis after coronary artery stenting.
|
Cytokine
|
2003
|
0.91
|
|
169
|
Urokinase receptor surface expression regulates monocyte adhesion in acute myocardial infarction.
|
Blood
|
2002
|
0.91
|
|
170
|
Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials.
|
Thromb Haemost
|
2007
|
0.91
|
|
171
|
Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.
|
Arterioscler Thromb Vasc Biol
|
2005
|
0.91
|
|
172
|
Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.
|
Eur Heart J
|
2009
|
0.91
|
|
173
|
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) study.
|
Am Heart J
|
2009
|
0.90
|
|
174
|
Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention.
|
Eur Heart J
|
2008
|
0.90
|
|
175
|
No association of polymorphisms in the gene encoding 5-lipoxygenase-activating protein and myocardial infarction in a large central European population.
|
Genet Med
|
2007
|
0.90
|
|
176
|
Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials.
|
Clin Res Cardiol
|
2010
|
0.90
|
|
177
|
Uric acid and prognosis in angiography-proven coronary artery disease.
|
Eur J Clin Invest
|
2012
|
0.90
|
|
178
|
LocaLisa catheter navigation reduces fluoroscopy time and dosage in ablation of atrial flutter: a prospective randomized study.
|
J Cardiovasc Electrophysiol
|
2003
|
0.89
|
|
179
|
Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with diabetes mellitus: a patient-level meta-analysis of randomized trials.
|
Clin Res Cardiol
|
2011
|
0.89
|
|
180
|
High-sensitivity troponin T level and angiographic severity of coronary artery disease.
|
Am J Cardiol
|
2011
|
0.89
|
|
181
|
Association of variants in the BAT1-NFKBIL1-LTA genomic region with protection against myocardial infarction in Europeans.
|
Hum Mol Genet
|
2007
|
0.89
|
|
182
|
ABO locus O1 allele and risk of myocardial infarction.
|
Blood Coagul Fibrinolysis
|
2004
|
0.89
|
|
183
|
A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy.
|
Am Heart J
|
2004
|
0.89
|
|
184
|
Everolimus-eluting versus sirolimus-eluting stents: an updated meta-analysis of randomized trials.
|
Clin Res Cardiol
|
2012
|
0.88
|
|
185
|
Choice of contrast medium in patients with impaired renal function undergoing percutaneous coronary intervention.
|
Circ Cardiovasc Interv
|
2009
|
0.88
|
|
186
|
Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
|
JACC Cardiovasc Interv
|
2008
|
0.88
|
|
187
|
A double-blind, randomized study on prevention and existence of a rebound phenomenon of platelets after cessation of clopidogrel treatment.
|
J Am Coll Cardiol
|
2010
|
0.88
|
|
188
|
Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent.
|
Ann Intern Med
|
2005
|
0.88
|
|
189
|
A randomized trial comparing myocardial salvage achieved by coronary stenting versus balloon angioplasty in patients with acute myocardial infarction considered ineligible for reperfusion therapy.
|
J Am Coll Cardiol
|
2004
|
0.88
|
|
190
|
Lack of support for association between common variation in TNFSF4 and myocardial infarction in a German population.
|
Nat Genet
|
2008
|
0.88
|
|
191
|
Turbulence dynamics: an independent predictor of late mortality after acute myocardial infarction.
|
Int J Cardiol
|
2006
|
0.88
|
|
192
|
Early resolution of ST-segment elevation correlates with myocardial salvage assessed by Tc-99m sestamibi scintigraphy in patients with acute myocardial infarction after mechanical or thrombolytic reperfusion therapy.
|
Circulation
|
2002
|
0.88
|
|
193
|
Tissue factor promotor polymorphism -603 A/G is associated with myocardial infarction.
|
Atherosclerosis
|
2004
|
0.88
|
|
194
|
Prevention of restenosis by systemic drug therapy: back to the future?
|
Circulation
|
2005
|
0.87
|
|
195
|
Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting.
|
Eur Heart J
|
2004
|
0.87
|
|
196
|
Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction.
|
Thromb J
|
2009
|
0.87
|
|
197
|
Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization.
|
J Am Coll Cardiol
|
2004
|
0.87
|
|
198
|
Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency.
|
Am J Cardiol
|
2003
|
0.87
|
|
199
|
Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate, and vitamin B12 levels and the extent of coronary artery disease.
|
Am J Cardiol
|
2004
|
0.87
|
|
200
|
Delineation of intra-atrial reentrant tachycardia circuits after mustard operation for transposition of the great arteries using biatrial electroanatomic mapping and entrainment mapping.
|
J Cardiovasc Electrophysiol
|
2003
|
0.87
|
|
201
|
Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties.
|
Mol Pharmacol
|
2004
|
0.87
|
|
202
|
4G/5G polymorphism and haplotypes of SERPINE1 in atherosclerotic diseases of coronary arteries.
|
Thromb Haemost
|
2010
|
0.86
|
|
203
|
EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture.
|
Thromb Haemost
|
2006
|
0.86
|
|
204
|
Non-invasive imaging of glycoprotein VI binding to injured arterial lesions.
|
Thromb Haemost
|
2005
|
0.86
|
|
205
|
Coagulation factor Xa stimulates interleukin-8 release in endothelial cells and mononuclear leukocytes: implications in acute myocardial infarction.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.86
|
|
206
|
Prognostic significance of epicardial blood flow before and after percutaneous coronary intervention in patients with acute coronary syndromes.
|
J Am Coll Cardiol
|
2008
|
0.85
|
|
207
|
Relationship between residual blood flow in the infarct-related artery and scintigraphic infarct size, myocardial salvage, and functional recovery in patients with acute myocardial infarction.
|
J Nucl Med
|
2005
|
0.85
|
|
208
|
Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease.
|
Clin Res Cardiol
|
2012
|
0.85
|
|
209
|
Images in cardiovascular medicine. Assessment of cor triatriatum sinistrum by magnetic resonance imaging.
|
Circulation
|
2003
|
0.85
|
|
210
|
Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence.
|
Hum Mol Genet
|
2008
|
0.85
|
|
211
|
Peak cardiac troponin-T level, scintigraphic myocardial infarct size and one-year prognosis in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction.
|
Am J Cardiol
|
2010
|
0.85
|
|
212
|
The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
|
Eur Heart J
|
2004
|
0.85
|
|
213
|
4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
|
Am Heart J
|
2003
|
0.85
|
|
214
|
Everolimus-eluting versus sirolimus-eluting stents: a meta-analysis of randomized trials.
|
Circ Cardiovasc Interv
|
2011
|
0.85
|
|
215
|
Fibrinogen genes and myocardial infarction: a haplotype analysis.
|
Arterioscler Thromb Vasc Biol
|
2008
|
0.84
|
|
216
|
EMAP-II downregulation contributes to the beneficial effects of rapamycin after vascular injury.
|
Cardiovasc Res
|
2007
|
0.84
|
|
217
|
Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography.
|
Int J Cardiovasc Imaging
|
2014
|
0.84
|
|
218
|
Impact of myocardial salvage assessed by (99m)Tc-sestamibi scintigraphy on cardiac autonomic function in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.
|
JACC Cardiovasc Imaging
|
2009
|
0.84
|
|
219
|
Outcome after out-of-hospital cardiac arrest in a physician-staffed emergency medical system according to the Utstein style.
|
Am Heart J
|
2007
|
0.84
|
|
220
|
Variations of specific non-candidate genes and risk of myocardial infarction: a replication study.
|
Int J Cardiol
|
2009
|
0.84
|
|
221
|
Impact of body mass index on platelet aggregation after administration of a high loading dose of 600 mg of clopidogrel before percutaneous coronary intervention.
|
Am J Cardiol
|
2007
|
0.84
|
|
222
|
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
|
Am Heart J
|
2011
|
0.84
|
|
223
|
Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: a randomized double-blind controlled trial.
|
Catheter Cardiovasc Interv
|
2005
|
0.84
|
|
224
|
Comparative efficacy of 2 zotarolimus-eluting stent generations: resolute versus endeavor stents in patients with coronary artery disease.
|
Am Heart J
|
2012
|
0.84
|
|
225
|
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.
|
Thromb Haemost
|
2010
|
0.83
|
|
226
|
Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
|
Arterioscler Thromb Vasc Biol
|
2003
|
0.83
|
|
227
|
Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
|
FASEB J
|
2004
|
0.83
|
|
228
|
Correlation of a new point-of-care test with conventional optical aggregometry for the assessment of clopidogrel responsiveness.
|
Thromb Haemost
|
2006
|
0.83
|
|
229
|
Circulating homocysteine levels in patients with type 2 diabetes mellitus.
|
Nutr Metab Cardiovasc Dis
|
2006
|
0.83
|
|
230
|
Troponin level and efficacy of abciximab in patients with acute coronary syndromes undergoing early intervention after clopidogrel pretreatment.
|
Clin Res Cardiol
|
2007
|
0.83
|
|
231
|
Prognostic value of coronary computed tomographic angiography in asymptomatic patients.
|
Am J Cardiol
|
2010
|
0.83
|
|
232
|
Genotyping of the angiotensin I-converting enzyme gene insertion/deletion polymorphism by the TaqMan method.
|
Clin Chem
|
2005
|
0.83
|
|
233
|
Two rare variants explain association with acute myocardial infarction in an extended genomic region including the apolipoprotein(A) gene.
|
Ann Hum Genet
|
2013
|
0.83
|
|
234
|
A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia.
|
Hum Mol Genet
|
2003
|
0.83
|
|
235
|
Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
|
Thromb Haemost
|
2007
|
0.83
|
|
236
|
Electrophysiologic characteristics of the spontaneous onset and termination of atrial fibrillation.
|
Am J Cardiol
|
2002
|
0.82
|
|
237
|
Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease.
|
Clin Res Cardiol
|
2010
|
0.82
|
|
238
|
Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice.
|
Arterioscler Thromb Vasc Biol
|
2003
|
0.82
|
|
239
|
No association of ABCB1 C3435T genotype with clopidogrel response or risk of stent thrombosis in patients undergoing coronary stenting.
|
Circ Cardiovasc Interv
|
2012
|
0.82
|
|
240
|
Giant coronary aneurysm obstructing the right heart.
|
Lancet
|
2006
|
0.82
|
|
241
|
Systemic inflammatory changes after pulmonary vein radiofrequency ablation do not alter stem cell mobilization.
|
Europace
|
2008
|
0.82
|
|
242
|
Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes.
|
Am J Kidney Dis
|
2004
|
0.82
|
|
243
|
Accuracy of N-terminal pro-brain natriuretic peptide to predict mortality in various subsets of patients with coronary artery disease.
|
Am J Cardiol
|
2007
|
0.81
|
|
244
|
Predictive factors for early cardiac events and angiographic restenosis after coronary stent placement in small coronary arteries.
|
J Am Coll Cardiol
|
2002
|
0.81
|
|
245
|
A prospective cohort study of prognostic power of N-terminal probrain natriuretic peptide in patients with non-ST segment elevation acute coronary syndromes.
|
Clin Res Cardiol
|
2006
|
0.81
|
|
246
|
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.
|
Am Heart J
|
2010
|
0.81
|
|
247
|
A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.
|
J Am Coll Cardiol
|
2005
|
0.81
|
|
248
|
Impact of lesion complexity on the capacity of a trial to detect differences in stent performance: results from the ISAR-STEREO trial.
|
Am Heart J
|
2003
|
0.81
|
|
249
|
Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention.
|
Heart Vessels
|
2010
|
0.81
|
|
250
|
Clopidogrel therapy in patients undergoing coronary stenting: value of a high-loading-dose regimen.
|
Catheter Cardiovasc Interv
|
2002
|
0.81
|
|
251
|
Interleukin 18 gene variation and risk of acute myocardial infarction.
|
Cytokine
|
2011
|
0.80
|
|
252
|
Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons.
|
JAMA
|
2007
|
0.80
|
|
253
|
The only better alternative to rescue percutaneous coronary intervention is primary percutaneous coronary intervention.
|
J Am Coll Cardiol
|
2009
|
0.80
|
|
254
|
Validity of cardiac implantable electronic devices in assessing daily physical activity.
|
Int J Cardiol
|
2012
|
0.80
|
|
255
|
Second-versus first-generation "Limus"-eluting stents in diabetic patients with coronary artery disease: a randomized comparison in setting of ISAR-TEST-4 trial.
|
Catheter Cardiovasc Interv
|
2013
|
0.80
|
|
256
|
Effects of G-CSF on systemic inflammation, coagulation and platelet activation in patients with acute myocardial infarction.
|
Thromb Res
|
2010
|
0.80
|
|
257
|
N-terminal probrain natriuretic peptide and C-reactive protein in stable coronary heart disease.
|
Am J Med
|
2006
|
0.80
|
|
258
|
Value of serum ferritin and soluble transferrin receptor for prediction of coronary artery disease and its clinical presentations.
|
Atherosclerosis
|
2004
|
0.80
|
|
259
|
Intra-aortic balloon counterpulsation in patients with acute myocardial infarction without cardiogenic shock. A meta-analysis of randomized trials.
|
Am Heart J
|
2012
|
0.80
|
|
260
|
One-year clinical outcomes with abciximab in acute myocardial infarction: results of the BRAVE-3 randomized trial.
|
Clin Res Cardiol
|
2010
|
0.80
|
|
261
|
Platelet function in clopidogrel-treated patients with acute coronary syndrome.
|
Blood Coagul Fibrinolysis
|
2007
|
0.79
|
|
262
|
Haptoglobin gene subtyping by restriction enzyme analysis.
|
Clin Chem
|
2003
|
0.79
|
|
263
|
Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trial.
|
J Am Coll Cardiol
|
2007
|
0.79
|
|
264
|
Assessment of platelet response to clopidogrel with multiple electrode aggregometry, the VerifyNow P2Y12 analyzer and platelet Vasodilator-Stimulated Phosphoprotein flow cytometry.
|
Blood Coagul Fibrinolysis
|
2010
|
0.79
|
|
265
|
Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting.
|
J Lipid Res
|
2004
|
0.79
|
|
266
|
Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention.
|
Clin Sci (Lond)
|
2009
|
0.79
|
|
267
|
Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
|
Circ Cardiovasc Interv
|
2012
|
0.79
|
|
268
|
A patient with stent thrombosis, clopidogrel-resistance and failure to metabolize clopidogrel to its active metabolite.
|
Thromb Haemost
|
2005
|
0.78
|
|
269
|
Association of uric acid with mortality in patients with stable coronary artery disease.
|
Metabolism
|
2012
|
0.78
|
|
270
|
Prehospital statin therapy and one-year mortality in patients with stable coronary artery disease undergoing percutaneous coronary intervention.
|
Eur J Intern Med
|
2012
|
0.78
|
|
271
|
Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality.
|
Am J Cardiol
|
2009
|
0.78
|
|
272
|
A prospective cohort study of predictive value of homocysteine in patients with type 2 diabetes and coronary artery disease.
|
Clin Chim Acta
|
2006
|
0.78
|
|
273
|
Comparative analysis of stent placement versus balloon angioplasty in small coronary arteries with long narrowings (the Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries [ISAR-SMART] Trial).
|
Am J Cardiol
|
2002
|
0.78
|
|
274
|
Oral anticoagulation with coumarin derivatives and antiplatelet effects of clopidogrel.
|
Eur Heart J
|
2010
|
0.78
|
|
275
|
ST-segment resolution after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
|
Cardiol J
|
2012
|
0.78
|
|
276
|
Prognostic value of minimal blood flow restoration in patients with acute myocardial infarction after reperfusion therapy.
|
Clin Res Cardiol
|
2009
|
0.78
|
|
277
|
Sex and effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions: results from Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 2 trial.
|
Am Heart J
|
2007
|
0.78
|
|
278
|
Images in cardiovascular medicine. Subacute thrombotic occlusion and spontaneous recanalization of the right coronary artery after percutaneous coronary intervention for ST-elevation myocardial infarction visualized by coronary angiography and cardiac magnetic resonance imaging.
|
Circulation
|
2007
|
0.78
|
|
279
|
Prognostic value of coronary computed tomographic angiography in patients with arterial hypertension.
|
Int J Cardiovasc Imaging
|
2011
|
0.78
|
|
280
|
Extended evidence for association between the melanoma inhibitory activity 3 gene and myocardial infarction.
|
Thromb Haemost
|
2011
|
0.78
|
|
281
|
A prospective randomized trial comparing the recovery of platelet function after loading dose administration of prasugrel or clopidogrel.
|
Platelets
|
2012
|
0.78
|
|
282
|
Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease.
|
Clin Sci (Lond)
|
2013
|
0.78
|
|
283
|
Vascular remodeling in mice lacking the cytoplasmic domain of tissue factor.
|
Circ Res
|
2005
|
0.78
|
|
284
|
Randomized trial of rapamycin- and paclitaxel-eluting stents with identical biodegradable polymeric coating and design.
|
Eur Heart J
|
2007
|
0.78
|
|
285
|
Predictive factors for in-stent late loss and coronary lesion progression in patients with type 2 diabetes mellitus randomized to rosiglitazone or placebo.
|
Am Heart J
|
2009
|
0.78
|
|
286
|
Intracoronary stenting and angiographic results: Restenosis after direct stenting versus stenting with predilation in patients with symptomatic coronary artery disease (ISAR-DIRECT trial).
|
Catheter Cardiovasc Interv
|
2004
|
0.78
|
|
287
|
Influence of high-pass filtering on noncontact mapping and ablation of atrial tachycardias.
|
Pacing Clin Electrophysiol
|
2004
|
0.78
|
|
288
|
Accuracy of N-terminal probrain natriuretic peptide to predict mortality or detect acute ischemia in patients with coronary artery disease.
|
Cardiology
|
2007
|
0.78
|
|
289
|
Accidental transarterial implantation of dual chamber pacemaker leads in the left ventricle and the right coronary artery.
|
Pacing Clin Electrophysiol
|
2005
|
0.77
|
|
290
|
Trends in radiation protection in CT: present and future status.
|
J Cardiovasc Comput Tomogr
|
2009
|
0.77
|
|
291
|
Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
|
Am J Kidney Dis
|
2009
|
0.77
|
|
292
|
Lower prevalence of the OCT2 Ser270 allele in patients with essential hypertension.
|
Clin Exp Hypertens
|
2006
|
0.77
|
|
293
|
Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.
|
Thromb Haemost
|
2010
|
0.77
|
|
294
|
Statin pretreatment and presentation patterns in patients with coronary artery disease.
|
Cardiol J
|
2013
|
0.77
|
|
295
|
Expression of CXCR4, VLA-1, LFA-3 and transducer of ERB in G-CSF-mobilised progenitor cells in acute myocardial infarction.
|
Thromb Haemost
|
2010
|
0.77
|
|
296
|
Gender differences in contrast-enhanced magnetic resonance imaging after acute myocardial infarction.
|
Int J Cardiovasc Imaging
|
2012
|
0.77
|
|
297
|
Overexpression of glycosyl phosphatidylinositol-anchored tissue factor pathway inhibitor-1 inhibits tissue factor activity.
|
Blood Coagul Fibrinolysis
|
2003
|
0.77
|
|
298
|
Diagnostic value of standard and extended ECG leads for the detection of acute myocardial infarction as compared to contrast-enhanced magnetic resonance imaging.
|
Int J Cardiol
|
2011
|
0.77
|
|
299
|
N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis.
|
Am J Cardiol
|
2006
|
0.77
|
|
300
|
Lack of association between circulating levels of plasma oxidized low-density lipoproteins and clinical outcome after coronary stenting.
|
Am Heart J
|
2005
|
0.77
|
|
301
|
High frequency of CYP2C19*2 carriers in PCI-treated patients switched over from clopidogrel to prasugrel based on platelet function monitoring.
|
Platelets
|
2012
|
0.77
|
|
302
|
Three-dimensional echocardiographic optimization improves outcome in cardiac resynchronization therapy compared to ECG optimization: a randomized comparison.
|
Pacing Clin Electrophysiol
|
2013
|
0.77
|
|
303
|
Glycoprotein IIb/IIIa receptor inhibition with abciximab during percutaneous coronary interventions increases the risk of bleeding in patients with impaired renal function.
|
Cardiology
|
2008
|
0.77
|
|
304
|
Serum potassium levels on admission and infarct size in patients with acute myocardial infarction.
|
Clin Chim Acta
|
2009
|
0.77
|
|
305
|
Estimate of myocardial salvage in late presentation acute myocardial infarction by comparing functional and perfusion abnormalities in predischarge gated SPECT.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.77
|
|
306
|
Sensitive troponin and N-terminal probrain natriuretic peptide in stable angina.
|
Eur J Clin Invest
|
2011
|
0.77
|
|
307
|
Myocardial gene expression of matched hibernating and control tissue from patients with ischemic left ventricular dysfunction.
|
Heart Vessels
|
2008
|
0.77
|
|
308
|
Dangerous liaison: successful percutaneous edge-to-edge mitral valve repair in patients with end-stage systolic heart failure can cause left ventricular thrombus formation.
|
EuroIntervention
|
2014
|
0.77
|
|
309
|
Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting.
|
Thromb Haemost
|
2013
|
0.76
|
|
310
|
Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
|
J Endovasc Ther
|
2003
|
0.76
|
|
311
|
Abciximab and angiographic restenosis after coronary stent placement. Analysis of the angiographic substudy of ISAR-REACT--a double-blind, placebo-controlled, randomized trial evaluating abciximab in patients undergoing elective percutaneous coronary interventions after pretreatment with a high loading dose of clopidogrel.
|
Am Heart J
|
2006
|
0.76
|
|
312
|
Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12 to 48 hours from onset of symptoms.
|
JAMA
|
2009
|
0.76
|
|
313
|
Pulmonary vein internal electrical activity does not contribute to the maintenance of atrial fibrillation.
|
Pacing Clin Electrophysiol
|
2003
|
0.76
|
|
314
|
Comparison of stenting with balloon angioplasty for lesions of small coronary vessels in patients with diabetes mellitus.
|
Am J Med
|
2002
|
0.76
|
|
315
|
Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis.
|
JACC Cardiovasc Interv
|
2009
|
0.76
|
|
316
|
Influence of abciximab on evolution of left ventricular function in patients with non-ST-segment elevation acute coronary syndromes undergoing PCI after clopidogrel pretreatment: lessons from the ISAR-REACT 2 trial.
|
Clin Res Cardiol
|
2011
|
0.76
|
|
317
|
Statin effect on thrombin inhibitor effectiveness during percutaneous coronary intervention: a post-hoc analysis from the ISAR-REACT 3 trial.
|
Clin Res Cardiol
|
2011
|
0.76
|
|
318
|
Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention.
|
Heart Vessels
|
2010
|
0.75
|
|
319
|
Acute beneficial hemodynamic effects of a novel 3D-echocardiographic optimization protocol in cardiac resynchronization therapy.
|
PLoS One
|
2012
|
0.75
|
|
320
|
Iron status and clinical outcome in patients with coronary artery disease after coronary stenting.
|
Nutr Metab Cardiovasc Dis
|
2005
|
0.75
|
|
321
|
Is it time to jettison complex mechanical thrombectomy in favor of simple manual aspiration devices?
|
J Am Coll Cardiol
|
2010
|
0.75
|
|
322
|
Are sirolimus-eluting stents superior to paclitaxel-eluting stents in patients with small-vessel disease?
|
Nat Clin Pract Cardiovasc Med
|
2008
|
0.75
|
|
323
|
Assessment of platelet function in whole blood by multiple electrode aggregometry: transport of samples using a pneumatic tube system.
|
Am J Clin Pathol
|
2009
|
0.75
|
|
324
|
Drug-eluting stents is their future as bright as their past?
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
325
|
Distal embolic protection in patients with acute myocardial infarction: attractive concept but no evidence of benefit.
|
JAMA
|
2005
|
0.75
|
|
326
|
Late constrictive involvement of the pericardium in a case of previous myocarditis.
|
Cardiovasc Pathol
|
2004
|
0.75
|
|
327
|
Plasminogen and matrix metalloproteinase activation by enzymatically modified low density lipoproteins in monocytes and smooth muscle cells.
|
Thromb Haemost
|
2005
|
0.75
|
|
328
|
ISAR--a story of trials with impact on practice.
|
Circ J
|
2010
|
0.75
|
|
329
|
TaqMan assays for genotyping of single nucleotide polymorphisms present at a disease susceptibility locus on chromosome 6.
|
Clin Chem Lab Med
|
2005
|
0.75
|
|
330
|
Images in cardiovascular medicine. Penetrating atherosclerotic ulcer of the aortic arch.
|
Circulation
|
2003
|
0.75
|
|
331
|
Images in cardiovascular medicine. Real-time perfusion echocardiography of an intracardiac mass.
|
Circulation
|
2003
|
0.75
|
|
332
|
Prognostic value of impaired fasting glucose for outcomes of patients with stable angina pectoris treated with percutaneous coronary interventions.
|
Am J Cardiol
|
2005
|
0.75
|
|
333
|
Sustained increased risk of adverse cardiac events over 5 years after implantation of gold-coated coronary stents.
|
Catheter Cardiovasc Interv
|
2006
|
0.75
|
|
334
|
Acute coronary artery stent thrombosis following rapid renewal of functional platelets: implications for intensified antiplatelet therapy.
|
Thromb Haemost
|
2006
|
0.75
|
|
335
|
Electrocardiographic algorithm for assignment of occluded vessel in acute myocardial infarction.
|
Int J Cardiol
|
2003
|
0.75
|
|
336
|
Gadolinium-enhanced cardiovascular magnetic resonance for the detection and characterization of Loeffler endocarditis in patients with hypereosinophilic syndrome.
|
Int J Cardiol
|
2011
|
0.75
|
|
337
|
PlA polymorphism of the glycoprotein IIIa and efficacy of reperfusion therapy in patients with acute myocardial infarction.
|
Thromb Haemost
|
2004
|
0.75
|
|
338
|
Direct and indirect catheter-to-catheter carbonization caused by high power radiofrequency delivery via a large tip ablation electrode.
|
J Interv Cardiol
|
2002
|
0.75
|
|
339
|
Lack of impact of calcium-channel blockers on the pharmacodynamic effect and the clinical efficacy of clopidogrel after drug-eluting stenting.
|
Am Heart J
|
2011
|
0.75
|
|
340
|
[A friend in need is a friend indeed: the case of drug-eluting stents, diabetes and small vessel size].
|
Rev Esp Cardiol
|
2006
|
0.75
|
|
341
|
Impact of acute myocardial infarct location on myocardial salvage after stenting or thrombolysis (results from the STOPAMI 1 and 2 trials): Stent versus Thrombolysis for Occluded coronary arteries in Patients with Acute Myocardial Infarction.
|
Am J Cardiol
|
2003
|
0.75
|
|
342
|
Recurrence of in-stent restenosis in cardiac allograft vasculopathy following implantation of a sirolimus-eluting stent.
|
Transpl Int
|
2005
|
0.75
|
|
343
|
Comparison of prognostic value of high-sensitivity and conventional troponin T in patients with non-ST-segment elevation acute coronary syndromes.
|
Clin Chim Acta
|
2011
|
0.75
|
|
344
|
Oxidized low density lipoproteins, statin therapy and severity of coronary artery disease.
|
Clin Chim Acta
|
2005
|
0.75
|
|
345
|
Association of midregional proadrenomedullin with coronary artery stenoses, soft atherosclerotic plaques and coronary artery calcium.
|
Heart Vessels
|
2011
|
0.75
|
|
346
|
G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease.
|
Atherosclerosis
|
2003
|
0.75
|
|
347
|
Sex-associated differences in clinical outcomes after coronary stenting in patients with diabetes mellitus.
|
Am J Med
|
2004
|
0.75
|
|
348
|
Application of right atrial contiguous linear lesions: an in vivo efficacy validation of multipolar ablation catheters in an animal model.
|
Pacing Clin Electrophysiol
|
2002
|
0.75
|
|
349
|
Characterization of onset mechanism and waveform analysis in patients with atrial fibrillation using a high-resolution noncontact mapping system.
|
J Cardiovasc Electrophysiol
|
2003
|
0.75
|
|
350
|
Effect of abciximab on clinical and angiographic restenosis in patients with non-ST-segment elevation acute coronary syndromes.
|
Am J Cardiol
|
2008
|
0.75
|
|
351
|
Efficacy of reperfusion with primary percutaneous coronary intervention in patients with acute ST segment elevation myocardial infarction.
|
Clin Res Cardiol
|
2011
|
0.75
|
|
352
|
Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction.
|
Blood Coagul Fibrinolysis
|
2005
|
0.75
|
|
353
|
Unusual use of a standard percutaneous transluminal coronary angioplasty balloon catheter to the rescue.
|
Eur Heart J
|
2008
|
0.75
|
|
354
|
Images in cardiovascular medicine. Assessment of isolated right ventricular myocardial infarction by magnetic resonance imaging.
|
Circulation
|
2006
|
0.75
|
|
355
|
Myocardial salvage after reduced-dose thrombolysis combined with glycoprotein IIb/IIIa blockade versus thrombolysis alone in patients with acute myocardial infarction.
|
J Thromb Thrombolysis
|
2004
|
0.75
|